Link Cell Therapies
Biotechnology Research
San Carlos, CA 3,023 followers
A True CAR T Cell AND-Gate
Über uns
Link Cell Therapies was launched by Stanford founders Robbie Majzner and Crystal Mackall in partnership with investors Samsara BioCapital and Sheatree Capital. The company is developing a best-in-class logic-gate technology to spur a new generation of cell therapies for patients with solid tumors. Link’s “AND” gates require two cancer-associated targets for a CAR T cell to attack cancer cells, thereby providing specificity for killing of tumor cells while sparing healthy tissue. Combined with additional technologies under development, Link will advance a suite of exciting internal therapeutic programs while exploring opportunities for value creation with strategic partners.
- Industrie
- Biotechnology Research
- Größe des Unternehmens
- 2-10 Mitarbeiter
- Hauptsitz
- San Carlos, CA
- Typ
- In Privatbesitz
- Gegründet
- 2022
Standorte
-
Primäre
San Carlos, CA 94070, US